Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
- 1 July 1987
- Vol. 50 (2), 203-213
- https://doi.org/10.1016/0092-8674(87)90216-9
Abstract
No abstract availableFunding Information
- U.S. Public Health Service
- National Institutes of Health (MV32)
- American Cancer Society (CA 09241, GM 07261)
This publication has 42 references indexed in Scilit:
- Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.The Journal of Experimental Medicine, 1987
- Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteinsImmunology Today, 1986
- Tissue-specific phosphorylation of complement receptors CR1 and CR2.The Journal of Experimental Medicine, 1986
- Growth control of activated, synchronized murine B cells by the C3d fragment of human complementNature, 1985
- Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 moleculeEuropean Journal of Immunology, 1985
- Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cellsNature, 1984
- Epstein–Barr Virus Replication in Oropharyngeal Epithelial CellsNew England Journal of Medicine, 1984
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978
- Surface Markers on Human B and T LymphocytesScandinavian Journal of Immunology, 1976
- Autologous human B and T lymphoblastoid cell linesNature, 1974